| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.21 | 3e-05 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.099 | 0.06 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.098 | 0.07 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.091 | 0.09 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.097 | 0.09 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.062 | 0.2 |